Relative risk for CVT up after AZD1222 COVID-19 vaccine
Jun 14, 2022
Relative rates of hospital contacts for coagulation disorder and cerebrovascular disease increased after AZD1222 (Astra Zeneca) vaccination.
Antibody levels after COVID-19 vaccination inversely linked to body weight
May 23, 2022
An inverse correlation was sustained for up to six months following two doses of BNT162b2 (Pfizer–BioNTech) in a small cohort of healthy young and middle-aged adults.
Rollout of Pfizer COVID-19 vaccine saved lives, healthcare dollars
May 19, 2022
A model shows the vaccine tied to the prevention of 110,000 deaths and a resulting $30.4 billion direct healthcare cost savings.
FDA limits use of J&J COVID-19 vaccine due to blood clot risk
May 06, 2022
With safer two-dose vaccines such as Pfizer and Moderna widely available, the one-dose J&J shot should be limited, the FDA said.
Single dose of AZD7442 effectively prevents COVID-19
Apr 22, 2022
A relative risk reduction of 82.8% was seen in symptomatic COVID-19 at extended follow-up of a median of six months.
Early effectiveness assessed for fourth dose of BNT162b2 vaccine
Apr 21, 2022
The difference in absolute risk for three versus four doses was 180.1 and 68.8 cases per 100,000 for COVID-19-related hospitalization and severe COVID-19.
COVID-19 response coordinator says adults older than 60 should get second booster
Apr 18, 2022
The FDA authorized a second booster of the Pfizer and Moderna vaccines on March 29 for anyone 50 years and older.
Third mRNA COVID-19 vaccine dose appears to be safe
Apr 15, 2022
There were higher reports of low-severity adverse effects but no change in severe events.
Vaccination offers extra protection after SARS-CoV-2 infection
Apr 06, 2022
Two studies show additional protection against reinfection and COVID-19-linked hospitalization with vaccination.
FDA panel meets to craft future vaccine strategy
Apr 06, 2022
No official vote is planned, and no specific vaccine products will be discussed.